523620 Stock Overview
Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Phaarmasia Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹40.42 |
| 52 Week High | ₹46.20 |
| 52 Week Low | ₹21.97 |
| Beta | 0.83 |
| 1 Month Change | 38.85% |
| 3 Month Change | 12.28% |
| 1 Year Change | 48.06% |
| 3 Year Change | 23.23% |
| 5 Year Change | 130.31% |
| Change since IPO | 199.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 523620 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -8.1% | 1.4% | 2.8% |
| 1Y | 48.1% | 57.2% | 46.6% |
Return vs Industry: 523620 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 523620 exceeded the Indian Market which returned 46.6% over the past year.
Price Volatility
| 523620 volatility | |
|---|---|
| 523620 Average Weekly Movement | 11.0% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 523620's share price has been volatile over the past 3 months.
Volatility Over Time: 523620's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 13 | Yallapragada Naga Rao | www.phaarmasia.in |
Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. The company offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, and stanozolol cypionate injections. It also provides herbal products, such as herbal toothpaste, cough and sore throat reliver, and mouth ulcer gel under the Smyle brand name.
Phaarmasia Limited Fundamentals Summary
| 523620 fundamental statistics | |
|---|---|
| Market cap | ₹270.28m |
| Earnings (TTM) | -₹10.94m |
| Revenue (TTM) | ₹281.07m |
1.0x
P/S Ratio-25.2x
P/E RatioIs 523620 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 523620 income statement (TTM) | |
|---|---|
| Revenue | ₹281.07m |
| Cost of Revenue | ₹229.11m |
| Gross Profit | ₹51.96m |
| Other Expenses | ₹62.90m |
| Earnings | -₹10.94m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.60 |
| Gross Margin | 18.48% |
| Net Profit Margin | -3.89% |
| Debt/Equity Ratio | 1.9% |
How did 523620 perform over the long term?
See historical performance and comparison